Nurses’ Use of Hazardous Drug-Handling Precautions and Awareness of National Safety Guidelines
Main Article Content
Keywords
.
Abstract
This study aims to analyze the utilization patterns of personal protective equipment (PPE) among oncology nurses during the handling of hazardous drugs (HDs) and to evaluate their awareness and adherence to safety guidelines, specifically focusing on the impact of the latest National Institute for Occupational Safety and Health (NIOSH) Alert.
Design: Descriptive and correlational research design.
Setting: The study was conducted among oncology nurses in various healthcare facilities in a metropolitan area.
Sample: The sample includes 250 oncology nurses involved in the preparation and administration of chemotherapy.
Methods: Data was collected through a self-report survey where nurses described their use of HD safe-handling precautions and their awareness of safety guidelines, including the NIOSH Alert.
Main Research Variables: The study focused on the availability and utilization of biologic safety cabinets, as well as the usage of PPE among oncology nurses.
Findings: The study revealed that a significant proportion of nurses had a high level of education, experience, and certification in oncology nursing. However, a considerable percentage of respondents were unaware of the NIOSH Alert. The use of gloves during HD handling was widespread, but gown use remained relatively low, especially during drug preparation and administration. Double-gloving was uncommon. Nurses in certain healthcare settings reported less access to chemotherapy-designated PPE and lower adherence to safety protocols.
Conclusions: The study highlights the need for increased awareness among nurses regarding HD exposure risks and the importance of proper PPE utilization. It also emphasizes the role of employers in providing adequate PPE and promoting its consistent use. Additionally, there is a need for improved methods of disseminating safety guidelines to ensure better adherence among healthcare professionals.
Implications for Nursing: The findings underscore the importance of ongoing education and training for nurses on HD safety measures. Healthcare institutions should prioritize the provision of appropriate PPE and create a culture that encourages its regular use to minimize the risk of exposure to hazardous drugs.
References
2. American Society of Health-System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172–1191. doi:10.2146/ajhp050529
3. American Society of Hospital Pharmacists. (1985). Technical assistance bulletin on handling cytotoxic drugs in hospitals. American Journal of Hospital Pharmacists, 42, 131–137.
4. Connor, T.H. (1993). An evaluation of the permeability of disposable polypropylene-based protective gowns to a battery of cancer chemotherapy drugs. Applied Occupational and Environmental Hygiene, 8, 785–789.
5. Falck, K., Gröhn, P., Sorsa, M., Vainio, H., Heinonen, E., & Holsti, L.R. (1979). Mutagenicity in urine of nurses handling cytostatic drugs. Lancet, 1, 1250–1251. doi:10.1016/S0140-6736(79)91939-1
6. Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112–119.
7. Fuchs, J., Hengstler, J.G., Jung, D., Hiltl, G., Konietzko, J., & Oesch, F. (1995). DNA damage in nurses handling antineoplastic agents. Mutational Research, 342, 17–23. doi:10.1016/0165-1218(95)90086-1
8. Harrison, B.R. (2001). Risks of handling cytotoxic drugs. In M.C. Perry (Ed.), The chemotherapy source book (3rd ed., pp. 566–582.). Philadelphia, PA: Lippincott Williams and Wilkins.
9. Harrison, B.R., & Kloos, M.D. (1999). Penetration and splash protection of six disposable gown materials against fifteen antineoplastic drugs. Journal of Oncology Pharmacy Practice, 5, 61–66.
10. Kyprianou, M., Kapsou, M., Raftopoulos, V., & Soteriades, E.S. (2010). Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents. European Journal of Oncology Nursing, 14, 278–282. doi:10.1016/j.ejon.2010.01.025
11. Mahon, S.M., Casperson, D.S., Yackzan, S., Goodner, S., Hasse, B., Hawkins, J., . . . Witcher, V. (1994). Safe handling practices of cytotoxic drugs: The results of a chapter survey. Oncology Nursing Forum, 21, 1157–1165.
12. Martin, S. (2003). Chemotherapy handling and effects among nurses and their offspring (Unpublished doctoral dissertation). Columbia University, New York, NY.
13. Martin, S. (2005). Chemotherapy handling and effects among nurses and their offspring [Abstract]. Oncology Nursing Forum, 32, 425.
14. Martin, S., & Larson, E. (2003). Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncology Nursing Forum, 30, 575–581. doi:10.1188/03.ONF.575-581
15. McDiarmid, M.A., Oliver, M.S., Roth, T.S., Rogers, B., & Escalante, C. (2010). Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of Occupational and Environmental Medicine, 52, 1028–1034. doi:10.1097/JOM.0b013e3181f73ae6
16. National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Retrieved from http://www.cdc.gov/niosh/docs/2004-165/
17. Nieweg, R.M., de Boer, M., Dubbleman, R.C., Gall, H.E., Hesselman, G.M., Lenssen, P.C., . . . Slegt, J.H. (1994). Safe handling of antineoplastic drugs: Results of a survey. Cancer Nursing, 17, 501–511.
18. Occupational Safety and Health Administration. (1986). Guidelines for cytotoxic (antineoplastic) drugs (Publication No. 8-1.1). Washington, DC: Author.
19. Occupational Safety and Health Administration. (1995). Controlling occupational exposure to hazardous drugs. Retrieved from http://www.osha.gov/dts/osta/tom/tom_vi/otm_vi_2.html
20. Occupational Safety and Health Administration. (1996). Controlling occupational exposure to hazardous drugs. Occupational Safety and Health Administration. American Journal of Health-System Pharmacists, 53, 1669–1685.
21. Oncology Nursing Society. (1988). Cancer chemotherapy guidelines: Modules I–V. Pittsburgh, PA: Author.
22. Polovich, M. (2003). Safe handling of hazardous drugs. Pittsburgh, PA: Oncology Nursing Society.
23. Polovich, M., Whitford, J.M., & Olsen, M. (2009). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
24. Selevan, S.G., Lindbohm, M.L., Hornung, R.W., & Hemminki, K. (1985). A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313, 1173–1178. doi:10.1056/NEJM198511073131901
25. Stajicj, G.V., Barnett, C.W., Turner, S.V., & Henderson, C.A. (1986). Protective measures used by oncologic office nurses handling parenteral antineoplastic agents. Oncology Nursing Forum, 13(6), 47–49.
26. Stücker, I., Caillard, J.F., Collin, R., Gout, M., Poyen, D., & Hémon, D. (1990). Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scandinavian Journal of Work, Environment and Health, 16, 102–107.
27. Testa, A., Giachelia, M., Palma, S., Appolloni, M., Padua, L., Tranfo, G., . . . Cozzi, R. (2007). Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and Applied Pharmacology, 223, 46–55. doi:10.1016/j.taap.2007.05.006
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.